Regarding other clinical variables contemplated here, STC2 is an estrogen-responsive gene co-expressed with the estrogen receptor in breast cancer [45,46,47], but according to our results, we cannot rule out that the change in the expression of STC2 is linked with the gender of our patients. The gene discussed is ESR1; the disease is breast carcinoma.